Treatment of patients with metastatic urothelial cancer "Unfit" for cisplatin-based chemotherapy Review uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Cisplatin
  • Urologic Neoplasms

abstract

  • Additional studies to optimize treatment for this important subset of patients are needed. A uniform definition of unfit patients will lead to more uniform clinical trials, enhanced ability to interpret the results of these trials, and a greater likelihood of developing a viable strategy for regulatory approval.

publication date

  • June 10, 2011

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2011.34.8433

PubMed ID

  • 21555688

Additional Document Info

start page

  • 2432

end page

  • 8

volume

  • 29

number

  • 17